Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Ximluci, ranibizumab, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised

European Shortages Monitoring Platform (ESMP): Implementation guide for national competent authorities

European Shortages Monitoring Platform (ESMP) User guide for national competent authorities

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 40, Status: Authorised

Certification procedures for advanced therapies under development by micro-, small- and medium-sized enterprises (SMEs)

Agenda - Management Board meeting: 30 September 2026

Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Date of authorisation: 18/09/2026, Status: Authorised

Medicine shortages and availability issues

Outcomes of imposed non-interventional post-authorisation safety studies